The ELSA study reframes early detection of type 1 diabetes "ELSA Race Around the World," where international screening efforts act as coordinated checkpoints across continents. From Europe to North America, Australia and beyond, programmes are identifying at-risk individuals in the presymptomatic stages creating a shared map of disease risk and opportunity. Within this global race, ELSA contributes a UK-based platform for systematic screening, monitoring, and follow-up-aligning with international momentum to stay ahead of progression. The goal is not speed but synchronisation: a collective effort to intercept disease earlier, reduce harm, and ultimately change the natural history of type 1 diabetes worldwide

Professor Parth Narendran (Immunology and Immunotherapy)

The ELSA Study https://www.elsadiabetes.nhs.uk/

The ELSA Study is screening children (age 2-15) and young adults (age 16-17) for type 1 diabetes.

Children and young adults can have a simple finger stick blood test to find out their risk of developing type 1 diabetes in the future.

Currently open to families living in England, Scotland, Wales and Northern Ireland.